Enablence Technologies Inc (OP:ENAFF)
Price and Volume
Detailed Quote| Volume | 50 |
| Open | 6.950 |
| Bid (Size) | N/A (0) |
| Ask (Size) | N/A (0) |
| Prev. Close | 6.950 |
| Today's Range | 6.950 - 6.950 |
| 52wk Range | 1.580 - 16.00 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
56.6% below 52-week high
6.950
1.5852W Low
16.0052W High
Enablence Technologies Inc (ENAFF) traded between $1.58 and $16.00 over the past 52 weeks and last traded at $6.95, 56.6% below its 52-week high.
Past 12 Months
1W
1M
+$3.10
3M
+$1.46
6M
+$4.70
YTD
+$5.37
1Y
+$5.37
ENAFF was +339.9% over the past year, +208.9% over six months, +339.9% year to date.
12 Months vs Market
ENAFF
+339.9%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%
Over the past 12 months ENAFF returned +339.9% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.
Volume & Liquidity
0.03× 3-mo avg
Today 50
3-mo avg 2.0K
1W
50.0
1M
1.7K
3M
2.0K
6M
5.4K
YTD
5.1K
1Y
5.1K
ENAFF most recently traded 50 shares against a 3-month average daily volume of 2.0K.
More News
Read More
Frequently Asked Questions
Is Enablence Technologies Inc publicly traded?
Yes, Enablence Technologies Inc is publicly traded.
What exchange does Enablence Technologies Inc trade on?
Enablence Technologies Inc trades on the OTC Traded
What is the ticker symbol for Enablence Technologies Inc?
The ticker symbol for Enablence Technologies Inc is ENAFF on the OTC Traded
What is the current price of Enablence Technologies Inc?
The current price of Enablence Technologies Inc is 6.950
When was Enablence Technologies Inc last traded?
The last trade of Enablence Technologies Inc was at 09/30/26 02:26 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.